DEFERASIROX and PYREXIA

Overview

PYREXIA is the #4 most commonly reported adverse reaction for DEFERASIROX, manufactured by Novartis Pharmaceuticals Corporation. There are 1,464 FDA adverse event reports linking DEFERASIROX to PYREXIA. This represents approximately 2.9% of all 50,952 adverse event reports for this drug.

Patients taking DEFERASIROX who experience pyrexia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

PYREXIA is a less commonly reported adverse event for DEFERASIROX, but still significant enough to appear in the safety profile.

Other Side Effects of DEFERASIROX

In addition to pyrexia, the following adverse reactions have been reported for DEFERASIROX:

• DEATH — 4,694 reports
• DIARRHOEA — 2,335 reports
• SICKLE CELL ANAEMIA WITH CRISIS — 1,803 reports
• NAUSEA — 1,415 reports
• HAEMOGLOBIN DECREASED — 1,406 reports
• PNEUMONIA — 1,246 reports
• SERUM FERRITIN INCREASED — 1,174 reports
• MALAISE — 1,124 reports
• FATIGUE — 1,119 reports
• VOMITING — 1,095 reports

Other Drugs Associated with PYREXIA

The following drugs have also been linked to pyrexia in FDA adverse event reports:

Does DEFERASIROX cause PYREXIA?

PYREXIA has been reported as an adverse event in 1,464 FDA reports for DEFERASIROX. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is PYREXIA with DEFERASIROX?

PYREXIA accounts for approximately 2.9% of all adverse event reports for DEFERASIROX, making it a notable side effect.

What should I do if I experience PYREXIA while taking DEFERASIROX?

If you experience pyrexia while taking DEFERASIROX, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages